Merck & Co. Inc. buy Citigroup Inc.
Start price
05.02.25
/
50%
€86.00
Target price
05.02.26
€110.32
Performance (%)
17.91%
End price
06.02.26
€101.40
Summary
This prediction ended on 06.02.26 with a price of €101.40. The prediction had a final performance of 17.91%. Dividends of €0.81 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 10.849% | 10.849% | 21.842% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $125.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€93.60
28.01.25
28.01.25
€119.86
28.01.26
28.01.26
-4.91%
29.01.26
29.01.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€96.70
25.10.24
25.10.24
€120.32
25.10.25
25.10.25
-21.92%
26.10.25
26.10.25